Special Issues

Special Issues

We bring you special features throughout the year to enhance the depth of our hematology and oncology coverage

Focus on Myeloid Malignancies (Volume 5, Issue 6.1)

This supplement features FDA updates for the treatment of myeloid malignancies, new questions in acute myeloid leukemia, and more.

Focus on Lymphoid Malignancies (Volume 5, Issue 4.1)

This supplement features a look at the future of Hodgkin lymphoma treatment, the latest approvals for lymphoid malignancies, and more.

Focus on Classical Hematology (Volume 4, Issue 12.1)

In this special edition, we take a look at the latest updates in classical hematology, from a advances in gene therapy for hemophilia to a debate about intravenous iron in pregnant women with iron-deficiency anemia, and more.

Focus on Myeloid Malignancies (Volume 4, Issue 6.1)

This supplement features FDA updates, clinical trials, and the latest research in myeloid malignancies.

Focus on Lymphoma & Myeloma (Volume 4, Issue 4.1)

This supplement features a look at controversies in myeloma treatment, the future of immunotherapy for lymphoma, newly approved and investigational therapies, and more.

Focus on Immunotherapy (October 2017, Volume 3, Issue 12.1)

This special edition features a closer look at immunotherapy, including the challenges and obstacles of clinical trials, the state of CAR T-cell therapy, and immunotherapies in the development pipeline.

Focus on Myeloid Malignancies (May 2017, Volume 3, Issue 6.1)

This special edition features updates in the world of myeloid malignancies, including a review of investigational treatment options and news from recent hematologic conferences.

Focus on Rare Diseases (October 2016, Volume 2, Issue 10.1)

This supplement features FDA updates, clinical trials, policy updates, and the latest research in hematologic rare diseases.

Focus on Trainees & Fellows (September 2016, Volume 2, Issue 9.1)

This special edition features advice and resources for trainees and fellows.

Hematology Pipeline Update (February 2016, Volume 2, Issue 2.1)

This supplement features updated information on late-breaking drug approvals for bleeding disorders, leukemia, and myeloma.

Current Issue

September 2019 Volume 5 Issue 11

September 2019, Volume 5, Issue 11

This issue explores politics in the exam room, demystifies proteomic analysis in hematology, and more.